New hope for inoperable pancreatic cancer: testing a Triple-Threat treatment
NCT ID NCT07386704
Summary
This study is testing a three-part treatment for pancreatic cancer that cannot be removed by surgery. It combines a targeted drug (nimotuzumab) with radiation and standard chemotherapy. The main goal is to see if this combination can control the cancer's growth in the treated area for at least one year. The study will also monitor side effects and how long patients live without the cancer getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER NON-RESECTABLE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Radiotherapy Oncology, Peking University First Hospital
Beijing, Beijing Municipality, 100034, China
Conditions
Explore the condition pages connected to this study.